Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders Having Drug-Induced Weight Gain.
Phase of Trial: Phase IV
Latest Information Update: 16 Sep 2016
At a glance
- Drugs Aripiprazole (Primary) ; Clozapine; Olanzapine; Quetiapine; Risperidone
- Indications Bipolar disorders
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 05 Jul 2012 Actual patient number is 28 according to ClinicalTrials.gov.
- 05 Jul 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.